Skip to main content
logo
CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.650
+0.020 (0.76%)
At close: Aug 25, 2026, 4:00 PM EDT
2.620
-0.030 (-1.13%)
Pre-market: Aug 26, 2026, 6:09 AM EDT

CervoMed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
40731943--
Market Cap Growth
-52.57%278.47%-55.39%---
Enterprise Value
1546-2733--
Last Close Price
2.657.902.347.63--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
120.9418.241.986.06--
PB Ratio
1.564.010.495.87--
P/TBV Ratio
1.754.010.495.87--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
45.6611.43-4.60--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-----1.38-2.74
Net Debt / Equity Ratio
-1.09-1.14-0.99-1.06-0.92-0.92
Asset Turnover
0.010.120.371.01--
Quick Ratio
8.234.5710.613.360.311.48
Current Ratio
8.574.9111.113.840.321.50
Return on Equity (ROE)
-107.62%-93.92%-69.95%---
Return on Assets (ROA)
-60.80%-53.62%-42.95%-69.12%-39.59%-
Return on Capital Employed (ROCE)
-135.70%-155.30%-46.50%-105.90%38.60%-223.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-75.75%-36.89%-84.35%-5.02%--
Buyback Yield / Dilution
-8.40%-12.00%-203.34%-413.65%88.49%-
SEC Filings: 10-K · 10-Q